Ghezzi P M, Gervasio R, Tessore V, Sartoris A M, Botella J
Nephrology Department, S. Croce Hospital, Cuneo, Italy.
ASAIO J. 1992 Jan-Mar;38(1):61-5. doi: 10.1097/00002480-199201000-00015.
Paired filtration dialysis (PFD) is the only hemodiafiltration (HDF) technique in which the ultrafiltrate is continuously available but not mixed with the dialysate. As is the case during all convective or predominantly convective techniques, use of a replacement fluid is necessary in an amount equal to the difference between the ultrafiltrate and the desired patient weight loss. This replacement fluid must have an adequate electrolytic composition (Na+, Ca++, and buffer), and must be sterile and pyrogen free. Using an uncoated adsorbent charcoal cartridge (130 g), the ultrafiltrate obtained in PFD was regenerated, eliminating both the small (except for urea, glucose, and phosphates) and medium-to-large solutes but not the electrolytes and bicarbonate. This verified the ultrafiltrate's possible use as replacement fluid. This technique experimentally studied during 24 standard PFD sessions, with a total mean ultrafiltrate of 9,950 +/- 860 ml, allowed a replacement solution to be obtained with the following mean +/- SD composition: pH 7.467 +/- 0.122, HCO3- 27.0 +/- 2.12 mmol/L, Na+ 137.4 +/- 2.6 mmol/L, K+ 4.1 +/- 0.83 mmol/L, Ca++ 1.12 +/- 0.19 mmol/L, urea 68.3 +/- 16.2 mg/dl, creatinine 0.08 +/- 0.02 mg/dl, uric acid 0.05 mg/dl, phosphates 2.77 +/- 0.71 mg/dl, beta-2 microglobulin 0.5 +/- 0.4 mg/L, and atrial natriuretic peptide 4.41 +/- 5.6 pg/ml.(ABSTRACT TRUNCATED AT 250 WORDS)
配对滤过透析(PFD)是唯一一种血液滤过透析(HDF)技术,在该技术中,超滤液可连续获取且不与透析液混合。与所有对流或主要为对流的技术一样,必须使用等量于超滤液与期望的患者体重减轻量之差的置换液。这种置换液必须具有适当的电解质组成(Na +、Ca ++和缓冲剂),并且必须无菌且无热原。使用未涂层的吸附性活性炭柱(130克),对PFD中获得的超滤液进行再生,可去除小溶质(除尿素、葡萄糖和磷酸盐外)以及中到大溶质,但不会去除电解质和碳酸氢盐。这证实了超滤液可作为置换液的可能性。在24次标准PFD治疗期间进行的这项技术实验研究中,超滤液总量平均为9,950±860毫升,得到的置换溶液平均组成如下(±标准差):pH 7.467±0.122,HCO3 - 27.0±2.12毫摩尔/升,Na + 137.4±2.6毫摩尔/升,K + 4.1±0.83毫摩尔/升,Ca ++ 1.12±0.19毫摩尔/升,尿素68.3±16.2毫克/分升,肌酐0.08±0.02毫克/分升,尿酸0.05毫克/分升,磷酸盐2.77±0.71毫克/分升,β-2微球蛋白0.5±0.4毫克/升,心房利钠肽4.41±5.6皮克/毫升。(摘要截选至250字)